Profound Medical Corp.
Profound Medical Corp. (PROF) Revenue
Annual & quarterly revenue history · segment & region breakdown
PROF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsProfound Medical Corp. trailing twelve-month (TTM) revenue is $0.02B, an increase of 61.10% year-over-year from $0.02B in FY2025.
Revenue trend
2025 – 2012 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.02B | +$0.01B | +61.10% |
| 2024-12-31 | $0.01B | +$0.00B | +41.23% |
| 2023-12-31 | $0.01B | +$0.00B | +7.75% |
| 2022-12-31 | $0.01B | -$0.00B | -2.79% |
| 2021-12-31 | $0.01B | -$0.00B | -5.90% |
| 2020-12-31 | $0.01B | +$0.00B | +74.99% |
| 2019-12-31 | $0.00B | +$0.00B | +118.47% |
| 2018-12-31 | $0.00B | -$0.00B | -61.04% |
| 2017-12-31 | $0.00B | +$0.00B | — |
| 2016-12-31 | $0.00B | +$0.00B | — |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Profound Medical Corp. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Profound Medical Corp. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Profound Medical Corp.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
PROF revenue · 4 questionsPROF's trailing twelve-month (TTM) revenue is $0.02B. That is an increase of 61.10% year-over-year from $0.02B in FY2025.
▸ Source: FMP · Profound Medical Corp. SEC filings · GAAP · Profound Medical Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026